TGTX

TG Therapeutics Inc (TGTX)

US
$ 00%

Price Chart

Key Statistics

Market Cap
$ 6.82B
P/E Ratio
289.60
Revenue (TTM)
$ 329M
Volume
0
52W High
$ 46.48
52W Low
$ 15.16
Dividend Yield
0.00%
Beta
2.14

Technicals

50-Day MA
38.1516
200-Day MA
29.6928
52 Week High
46.48
52 Week Low
15.16

About TGTX

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United State.

Employees
338
Headquarters
Morrisville, NC
CEO
Mr. Michael S. Weiss Esq.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
PLRZ
Polyrizon Ltd. Ordi...
$ 1.24
389.38
KIDZ
Classover Holdings ...
$ 9.17
71.09
FRGT
Freight Technologie...
$ 1.63
65.52
IBO
IBO (Listing Market...
$ 0.60
50.10
CPS
Cooper-Standard Hol...
$ 20.48
34.56

Top Losers

Symbol/Name
LTP
% Chg
ZCAR
Zoomcar Holdings In...
$ 7.57
-42.54
PDEX
Pro-Dex Inc. Common...
$ 45.86
-31.86
XYZ
Block Inc. Class A ...
$ 46.43
-20.61
NVNI
Nvni Group Limited ...
$ 0.33
-19.68
FUBO
fuboTV Inc. Common ...
$ 2.42
-17.41